Skip to main content
Pharmaceutical product and formulation background
Pharmaceutical Division

Ivacaftor

Ivacaftor is a CFTR potentiator used in combination therapies for the treatment of cystic fibrosis in patients with specific CFTR gene mutations.

Under developmentCystic fibrosisCAS 873054-44-5
✓Quality Assured
✓CFTR potentiator
✓Under development

Detailed technical, regulatory, and supply information is available for commercial evaluation.

Technical Overview

Ivacaftor – CAS 873054-44-5

Under development

CAS Number

873054-44-5

Category

Cystic fibrosis

Therapeutic Class

CFTR potentiator

Description

Ivacaftor is a CFTR potentiator used in combination therapies for the treatment of cystic fibrosis in patients with specific CFTR gene mutations.

Applications

  • Cystic fibrosis

Handling & Supply Details

Packaging

Standard export packaging in double-lined HDPE drums or fiber drums with inner poly liners; custom pack sizes available on request.

Product Inquiry

Disclaimer

Products offered are intended strictly for R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer.

This website uses cookies to optimize your navigation and adapt to your preferences. You can continue browsing without accepting. If you select "Accept", you accept the use of ALL cookies. You can also select cookies in "Cookie settings" and consult our Cookies Policy and Privacy Policy here.